Atlas Trials

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

Clinical trial NCT02459795 · COMPLETED

Trial details

NCT number
NCT02459795
Sponsor
Padagis LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2015-05-01
Primary completion
2015-12-01
Enrollment
469

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.